| Literature DB >> 31076469 |
Chen Wei1,2, Sunyue Ye1,2, Yuan Ru1,2, Da Gan1,2, Weifang Zheng3, Chao Huang1,2, Lijin Chen1,2, Peng Gao1,2, Jiayu Li1,2, Min Yang1,2, Fei Yang1,2, Xueyin Zhao1,2, Shankuan Zhu1,2.
Abstract
PURPOSE: The Lanxi Cohort was established to systematically investigate the aetiology and interplay of body fat distribution and multiple factors with obesity and obesity-related non-communicable diseases in China. PARTICIPANTS: The baseline investigation of the Lanxi Cohort study took place between June 2015 and August 2017 in Lanxi, Zhejiang Province, China. Permanent residents from one urban community and four rural villages were involved in this study. The baseline investigation included questionnaire survey, physical examination, dual-energy X-ray absorptiometry (DXA) scan, blood samples collection and traditional Chinese medicine (TCM) inquiry. FINDINGS TO DATA: A total of 5132 participants, aged 18 to 80 years, were recruited at baseline; among them, 38.7% were men and 64.8% were from the urban area. The mean age was 53.04±12.77 years. The completion rates of physical examination, DXA scan, blood collection and TCM inquiry were 99.9%, 98.5%, 99.9% and 96.5%, respectively. The mean body mass index (BMI) was 23.42±3.20 kg/m2 with 8.1% of the study population being obese (BMI ≥28 kg/m2). The crude prevalence of hypertension, diabetes and metabolic syndrome were 34.9%, 10.0% and 30.4%, respectively. FUTURE PLANS: All participants will be monitored annually for cause-specific mortality and morbidity and hospital admission and will be followed up by in-person survey every 4 years. The baseline population is considered to expand in the future depending on the availability of funding support. ETHICS APPROVAL: This study was approved by the Ethical Committee of the School of Public Health, Zhejiang University. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: body composition; cohort study; epidemiology; non-communicable disease; obesity; public health
Mesh:
Year: 2019 PMID: 31076469 PMCID: PMC6527990 DOI: 10.1136/bmjopen-2018-025257
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Location of Lanxi in China.
Figure 2Flowchart of participant recruitment.
Completion rate of each component at baseline in the Lanxi cohort study
| Components | Overall (n=5132) | Urban (n=3327) | Rural (n=1805) | |||
| N | % | N | % | N | % | |
| Questionnaire survey | 5027 | 98.0 | 3260 | 98.0 | 1767 | 97.90 |
| Physical examination | 5127 | 99.9 | 3320 | 99.8 | 1805 | 100.0 |
| Dual-energy X-ray absorptiometry | 5055 | 98.5 | 3263 | 98.1 | 1792 | 99.3 |
| Blood sample collection | 5128 | 99.9 | 3327 | 100.0 | 1801 | 99.8 |
| Traditional Chinese medicine | 4951 | 96.5 | 3202 | 96.2 | 1749 | 96.9 |
The basic characteristics of the participants at baseline in the Lanxi cohort study
| Characteristic | Overall (n=5132) | Urban (n=3327) | Rural (n=1805) | P value* | |||
| Mean or N | SD or % | Mean or N | SD or % | Mean or N | SD or % | ||
| Sex | |||||||
| Male | 1988 | 38.7 | 1260 | 37.87 | 728 | 40.3 | 0.084 |
| Female | 3144 | 61.3 | 2067 | 62.13 | 1077 | 59.7 | |
| Age (yrs) | |||||||
| 18–29 | 222 | 4.33 | 176 | 5.29 | 46 | 2.55 | <0.001 |
| 30–39 | 581 | 11.32 | 392 | 11.78 | 189 | 10.47 | |
| 40–49 | 1112 | 21.67 | 749 | 22.51 | 363 | 20.11 | |
| 50–59 | 1472 | 28.68 | 932 | 28.01 | 540 | 29.92 | |
| 60–69 | 1257 | 24.49 | 760 | 22.84 | 497 | 27.53 | |
| 70–80 | 488 | 9.51 | 318 | 9.56 | 170 | 9.42 | |
| Mean age (yrs) | 53.04 | 12.77 | 52.42 | 13.15 | 54.17 | 11.94 | <0.001 |
| Ethnics | |||||||
| Han | 5013 | 97.7 | 3250 | 97.7 | 1763 | 97.7 | 0.749 |
| Minority | 10 | 0.2 | 6 | 0.2 | 4 | 0.2 | |
| Unknown | 109 | 2.1 | 71 | 2.1 | 38 | 2.1 | |
| Education | |||||||
| Illiteracy | 922 | 17.8 | 478 | 14.4 | 444 | 24.6 | <0.001 |
| Primary school | 1061 | 20.7 | 510 | 15.3 | 551 | 30.5 | |
| Middle/high school | 2488 | 48.5 | 1783 | 53.6 | 705 | 39.1 | |
| College or above | 549 | 10.7 | 485 | 14.6 | 64 | 3.6 | |
| Unknown | 112 | 2.2 | 71 | 2.1 | 41 | 2.3 | |
| Marital status | |||||||
| Unmarried | 177 | 3.5 | 130 | 3.9 | 47 | 2.6 | <0.001 |
| Married | 4570 | 89.1 | 2913 | 87.6 | 1657 | 91.8 | |
| Ex-married | 276 | 5.4 | 216 | 6.5 | 60 | 3.3 | |
| Unknown | 109 | 2.1 | 68 | 2.0 | 41 | 2.3 | |
| Smoking | |||||||
| Never smoker | 3942 | 76.8 | 2551 | 76.7 | 1391 | 77.1 | 0.206 |
| Current smoker | 808 | 15.7 | 519 | 15.6 | 289 | 16.0 | |
| Former smoker | 269 | 5.2 | 188 | 5.7 | 81 | 4.5 | |
| Unknown | 113 | 2.2 | 69 | 2.1 | 44 | 2.4 | |
| Drinking | |||||||
| Never | 2723 | 53.1 | 1775 | 53.4 | 948 | 52.5 | <0.001 |
| <12/year | 973 | 19.0 | 581 | 17.5 | 392 | 21.7 | |
| ≥12/year | 1204 | 23.5 | 832 | 25.0 | 372 | 20.6 | |
| Former drinker | 117 | 2.3 | 68 | 2.0 | 49 | 2.7 | |
| Unknown | 115 | 2.2 | 71 | 2.1 | 44 | 2.4 | |
*Comparison between the urban and rural participants, Student’s t-test for continuous variables and χ2 test for categorical variables. yrs, years.
The baseline characteristics of anthropometry and body composition in the Lanxi cohort study
| Variables* | Overall | Urban | Rural | P value† | |||
| Mean | SD | Mean | SD | Mean | SD | ||
| Male participants | |||||||
| Weight (kg) | 66.32 | 9.95 | 66.60 | 9.76 | 65.86 | 10.24 | 0.113 |
| Standing height (cm) | 166.98 | 5.71 | 167.51 | 5.58 | 166.07 | 5.82 | <0.001 |
| Sitting height (cm) | 90.16 | 3.83 | 90.87 | 3.81 | 88.96 | 3.55 | <0.001 |
| Body mass index (kg/m2) | 23.76 | 3.15 | 23.71 | 3.11 | 23.84 | 3.23 | 0.392 |
| Waist circumference (cm) | 85.82 | 9.25 | 85.99 | 9.11 | 85.52 | 9.49 | 0.277 |
| Hip circumference (cm) | 91.81 | 5.64 | 92.20 | 5.56 | 91.13 | 5.73 | <0.001 |
| Waist-to-hip ratio | 0.93 | 0.07 | 0.93 | 0.06 | 0.94 | 0.07 | 0.071 |
| Body fat mass percent (%) | 22.67 | 6.61 | 23.59 | 6.30 | 21.10 | 6.82 | <0.001 |
| Body lean mass percent (%) | 73.08 | 6.50 | 72.34 | 6.24 | 74.34 | 6.75 | <0.001 |
| Trunk fat mass percent (%) | 61.79 | 5.12 | 61.81 | 4.93 | 61.76 | 5.42 | 0.833 |
| Android fat mass percent (%) | 11.77 | 1.34 | 11.69 | 1.29 | 11.91 | 1.42 | <0.001 |
| Gynoid fat mass percent (%) | 15.82 | 2.85 | 15.84 | 2.85 | 15.79 | 2.85 | 0.706 |
| Android-to-gynoid fat mass ratio | 0.78 | 0.19 | 0.77 | 0.19 | 0.79 | 0.20 | 0.034 |
| Female participants | |||||||
| Weight (kg) | 56.43 | 8.62 | 56.50 | 8.61 | 56.29 | 8.64 | 0.523 |
| Standing height (cm) | 155.86 | 5.45 | 156.29 | 5.30 | 155.06 | 5.63 | <0.001 |
| Sitting height (cm) | 84.71 | 3.71 | 85.27 | 3.67 | 83.63 | 3.55 | <0.001 |
| Body mass index (kg/m2) | 23.21 | 3.21 | 23.11 | 3.23 | 23.39 | 3.18 | 0.024 |
| Waist circumference (cm) | 80.80 | 9.30 | 80.39 | 9.31 | 81.59 | 9.24 | 0.001 |
| Hip circumference (cm) | 91.16 | 6.02 | 91.17 | 5.82 | 91.14 | 6.39 | 0.925 |
| Waist-to-hip ratio | 0.89 | 0.07 | 0.88 | 0.07 | 0.89 | 0.06 | <0.001 |
| Body fat mass percent (%) | 32.68 | 5.72 | 33.18 | 5.62 | 31.75 | 5.79 | <0.001 |
| Body lean mass percent (%) | 62.99 | 5.70 | 62.54 | 5.65 | 63.84 | 5.68 | <0.001 |
| Trunk fat mass percent (%) | 56.48 | 4.98 | 56.27 | 4.85 | 56.88 | 5.19 | 0.001 |
| Android fat mass percent (%) | 10.19 | 1.41 | 10.10 | 1.40 | 10.35 | 1.42 | <0.001 |
| Gynoid fat mass percent (%) | 17.42 | 2.98 | 17.50 | 2.95 | 17.25 | 3.03 | 0.027 |
| Android-to-gynoid fat mass ratio | 0.61 | 0.17 | 0.60 | 0.17 | 0.63 | 0.18 | <0.001 |
*The variable sample size varied due to that participants did not complete the physical examination or dual-energy X-ray absorptiometry scans.
†Comparison between the urban and rural male/female participants, Student’s t-test for continuous variables and X2 test for categorical variables.
The metabolic characteristics at baseline in the Lanxi cohort study
| Variables* | Overall | Urban | Rural | P value† | |||
| Mean | SD | Mean | SD | Mean | SD | ||
| Systolic blood pressure (mm Hg) | 124.61 | 19.07 | 122.76 | 19.32 | 128.01 | 18.12 | <0.001 |
| Diastolic blood pressure (mm Hg) | 78.74 | 10.72 | 78.21 | 11.15 | 79.71 | 9.81 | <0.001 |
| Fasting blood glucose (mmol/L) | 5.24 | 1.28 | 5.23 | 1.28 | 5.26 | 1.28 | 0.423 |
| HbA1c (%) | 5.61 | 0.90 | 5.67 | 0.92 | 5.52 | 0.84 | <0.001 |
| Insulin (μU/mL) | 6.90 | 6.42 | 6.74 | 6.94 | 7.19 | 5.32 | 0.016 |
| Triglyceride (mmol/L) | 1.76 | 1.51 | 1.78 | 1.50 | 1.72 | 1.52 | 0.183 |
| Cholesterol (mmol/L) | 4.69 | 0.95 | 4.80 | 0.98 | 4.49 | 0.86 | <0.001 |
| High-density lipoprotein (mmol/L) | 1.40 | 0.35 | 1.44 | 0.34 | 1.33 | 0.36 | <0.001 |
| Low-density lipoprotein (mmol/L) | 2.52 | 0.75 | 2.57 | 0.76 | 2.41 | 0.72 | <0.001 |
| Blood uric acid (μmol/L) | 307.57 | 84.66 | 311.71 | 85.13 | 299.99 | 83.27 | <0.001 |
| C-reactive protein (mg/L) | 1.50 | 3.46 | 1.59 | 3.60 | 1.35 | 3.17 | 0.021 |
*The variable sample size varied due to those participants did not donate blood samples.
†Comparison between the urban and rural participants, Student’s t-test for continuous variables and χ2 test for categorical variables. HbA1c, haemoglobin A1c.
The prevalence of selected metabolic disease at baseline in the Lanxi cohort study
| Variables* | Overall | Urban | Rural | P value† | |||
| N | %‡ | N | %‡ | N | %‡ | ||
| Obese§ | 409 | 8.1/9.0 | 255 | 7.8/8.7 | 154 | 8.6/9.7 | 0.34 |
| Central obese¶ | 2265 | 44.6/35.8 | 1423 | 43.3/34.7 | 842 | 46.9/39.1 | 0.015 |
| Hypertension** | 1744 | 34.9/25.0 | 1064 | 32.9/24.1 | 680 | 38.6/26.7 | <0.001 |
| Diabetes†† | 499 | 10.0/6.8 | 357 | 11.0/7.5 | 142 | 8.1/5.4 | 0.001 |
| Metabolic syndrome‡‡ | 1502 | 30.4/23.6 | 930 | 29.2/22.8 | 572 | 32.7/25.1 | 0.009 |
| Fatty liver§§ | 1678 | 33.1/30.9 | 1204 | 36.8/34.5 | 474 | 26.4/23.2 | <0.001 |
| Gallstone§§ | 670 | 13.2/8.5 | 489 | 14.9/9.8 | 181 | 10.1/6.1 | <0.001 |
| Coronary heart disease¶¶ |
| 2.2/1.2 | 88 | 2.7/1.5 | 22 | 1.3/0.6 | 0.001 |
*The variable sample size varied due to that participants did not complete physical examination or questionnaire, or did not donate blood samples.
†Comparison between the urban and rural participants, Student’s t-test for continuous variables and X2 test for categorical variables.
‡Crude/adjusted for age and gender using national census data in 2010.
§Body mass index ≥28 kg/m2.
¶Waist circumference ≥90 cm for men and waist circumference ≥80 cm for women.
**Systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/or self-reported history of hypertension.
††Fasting glucose ≥7.0 mmol/L and/or HbA1c ≥6.5% and/or self-reported history of diabetes.
‡‡Presence of any three of five risk factors: (1) waist circumference ≥90 cm for men and waist circumference ≥80 cm for women, (2) triglycerides ≥1.7 mmol/L or self-reported history of elevated triglycerides, (3) high-density lipoprotein <1.0 mmol/L for men and high-density lipoprotein <1.3 mmol/L for women or self-reported history of reduced high-density lipoprotein, (4) systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg or self-reported history of hypertension and (5) fasting glucose ≥5.6 mmol/L or self-reported history of elevated glucose.
§§According to diagnosis by ultrasonography.
¶¶According to the self-reported medical history by face-to-face interview.
HbA1c, haemoglobin A1c.